[1] Lin KY, Hsih WH, Lin YB, et al. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy[J]. J Diabetes Investig, 2021, 12: 1322-1325. [2] 肖艳新, 刘岩, 许岭翎, 等. 铁死亡在非酒精性脂肪性肝病发病中作用的研究进展[J]. 基础医学与临床, 2024, 44: 260-264. [3] Lu Y, Zhu F, Zhou X, et al. A supramolecular deferoxamine-crisaborole nanoparticle targets ferroptosis, inflammation, and oxidative stress in the treatment of retinal ischemia/reperfusion injury[J]. Nano Lett, 2025, 25: 1058-1066. [4] Ni Y, Hu Y, Zhu L, et al. Lycium barbarum polysaccharide-derived nanoparticles protect visual function by inhibiting RGC ferroptosis and microglial activation in retinal ischemia-reperfusion mice[J]. Adv Healthc Mater, 2024, 13: e2304285. doi: 10.1002/adhm.202304285. [5] Cheng J, Keuthan CJ, Esumi N. The many faces of SIRT6 in the retina and retinal pigment epithelium[J]. Front Cell Dev Biol, 2023, 11: 1244765.doi:10.3389/fcell.2023.1244765. [6] Zorrilla-Zubilete MA, Yeste A, Quintana FJ, et al. Epigenetic control of early neurodegenerative events in diabetic retinopathy by the histone deacetylase SIRT6[J]. J Neurochem, 2018, 144: 128-138. [7] Pourhanifeh MH, Hosseinzadeh A, Koosha F, et al. Therapeutic effects of melatonin in the regulation of ferroptosis: a review of current evidence[J]. Curr Drug Targets, 2024, 25: 543-557. [8] Chen L, Qi Y, Yang X. Neuroprotective effects of crocin against oxidative stress induced by ischemia/reperfusion injury in rat retina[J]. Ophthalmic Res, 2015, 54: 157-168. [9] Ishizuka F, Shimazawa M, Umigai N, et al. Crocetin, a carotenoid derivative, inhibits retinal ischemic damage in mice[J]. Eur J Pharmacol, 2013, 703: 1-10. [10] 常花蕾, 杨新光, 于敬妮, 等. 藏红花素对视网膜缺血再灌注损伤大鼠视网膜组织结构及肿瘤坏死因子-α、白细胞介素-1β表达的影响[J]. 中华眼底病杂志, 2013, 29: 300-304. [11] Wang X, Li M, Diao K, et al. Deferoxamine attenuates visual impairment in retinal ischemia-reperfusion via inhibiting ferroptosis[J]. Sci Rep, 2023, 13: 20145. doi: 10.1038/s41598-023-46104-0. [12] Hong R, Chen B, Wu H, et al. Crocin facilitates osteogenesis and angiogenesis by moderating oxidative stress and ferroptosis via Nrf2/GPX4 pathway[J]. Tissue Cell, 2025, 93: 102675. doi: 10.1016/j.tice.2024.102675. [13] Ma RX, Lin BH, Feng SX, et al. Evaluation of proanthocyanidins in treating type 2 diabetic osteoporosis via SIRT6/Nrf2/GPX4 pathways[J]. Faseb J, 2025, 39: e70487. doi: 10.1096/fj.202403032R. [14] 王瑶, 陈士坤, 段晨阳, 等. Sirt6通过调控P53/SLC7A11/GPX4通路抑制骨骼肌细胞铁死亡[J]. 中国病理生理杂志, 2023, 39: 335-344. [15] 彭甜, 丁琼蕾, 雷小保, 等. SIRT6在脓毒症急性肺损伤中的作用及其对铁死亡的影响[J]. 中华急诊医学杂志, 2025, 34: 207-210. |